Barriers for Pharmaceutical Innovation With Focus in Cancer Drugs, the Case of Mexico
Crossref DOI link: https://doi.org/10.1007/s43441-019-00062-w
Published Online: 2020-01-06
Published Print: 2020-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Duenas-Gonzalez, Alfonso https://orcid.org/0000-0002-2956-645X
Gonzalez-Fierro, Aurora
Text and Data Mining valid from 2020-01-06
Article History
Received: 7 November 2018
Accepted: 22 February 2019
First Online: 6 January 2020